Compare State Street SPDR S&P Biotech ETF (XBI) vs Zillow Group Inc Class A (ZG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
State Street SPDR S&P Biotech ETF vs Zillow Group Inc Class A — how do they compare? State Street SPDR S&P Biotech ETF trades at $154.5, while Zillow Group Inc Class A trades at $31.83 (market cap $7.54B). The key difference: State Street SPDR S&P Biotech ETF is trading nearer its 52-week high, Zillow Group Inc Class A nearer its low. Which is the better fit depends on your goals.
| XBI | ZG | |
|---|---|---|
Sector | Broad Market / Factor | Media |
52-Week High | $164.28 | $86.76 |
52-Week Low | $85.16 | $29.14 |
Market Cap | — | $7.54B |
Enterprise Value | — | $7.19B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About State Street SPDR S&P Biotech ETF
XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.
Read more on XBI →About Zillow Group Inc Class A
Zillow Group is an Internet-based real estate company that has historically focused on deriving ad revenue from third-party brokers on online marketplaces such as Zillow.com, Trulia, and HotPads. More recently it has shifted its focus to iBuying via the Zillow Offers platform.
Read more on ZG →
